Clinical trial / 2010
Daily almond intake reduced cholesterol and apolipoprotein B100 in men with hyperlipidemia.
In an uncontrolled trial of 30 men with mild hyperlipidemia, eating 60 g of almonds daily for 4 weeks significantly reduced total cholesterol, low-density lipoprotein cholesterol, and apolipoprotein B100. Supplementation also altered the correlation structure between lipid risk markers and copper-induced lipid oxidation parameters. Baseline showed little association, whereas post-supplementation total cholesterol correlated positively with oxidation lag-time (r = 0.6, p = 0.001) and negatively with maximal oxidation rate.
- Study type
- Before-after clinical trial
- Who was studied
- 30 men with mild hyperlipidemia
- What was measured
- serum lipids, apolipoproteins, and copper-induced lipid oxidation
THE PAPER
Effects of almond dietary supplementation on coronary heart disease lipid risk factors and serum lipid oxidation parameters in men with mild hyperlipidemia.
Jalali-Khanabadi BA, Mozaffari-Khosravi H, Parsaeyan N. J Altern Complement Med, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.